HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom.

HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom.

OBJECTIVE: To investigate the HLA class I associations of ankylosing spondylitis (AS) in the white population, with particular reference to HLA-B27 subtypes. METHODS: HLA-B27 and -B60 typing was performed in 284 white patients with AS. Allele frequencies of HLA-B27 and HLA-B60 from 5926 white bone m...

Bibliografske podrobnosti
Main Authors:	Brown, M, Pile, K, Kennedy, L, Calin, A, Darke, C, Bell, J, Wordsworth, B, Cornélis, F
Format:	Journal article
Jezik:	English
Izdano:	1996

Podobne knjige/članki

The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis.
od: Brown, M, et al.
Izdano: (1998)

Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment.
od: Brown, M, et al.
Izdano: (1997)

HLA-B associations of HLA-B27 negative ankylosing spondylitis: comment on the article by Yamaguchi et al.
od: Brown, M, et al.
Izdano: (1996)

Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis.
od: Burney, R, et al.
Izdano: (1994)

MHC class II and III genes are associated with ankylosing spondylitis independent of HLA-B27.
od: Sims, A, et al.
Izdano: (2004)

Characteristics of ankylosing spondylitis patients in the United Kingdom
od: Farrat, C, et al.
Izdano: (2008)

Mapping of MHC class II and III genes associated with Ankylosing spondylitis independent of HLA-B27
od: Sims, A, et al.
Izdano: (2005)

NO ADDITIONAL ROLE FOR THE MHC CLASS-II ENCODED COMPONENTS OF THE HLA CLASS-I PATHWAY OF ANTIGEN PRESENTATION (LMP2, TAP1-AND-2) IN THE ETIOLOGY OF ANKYLOSING-SPONDYLITIS (AS)
od: Pile, K, et al.
Izdano: (1993)

Non-B27 MHC associations of ankylosing spondylitis.
od: Sims, A, et al.
Izdano: (2007)

The role of B*60 in disease expression of ankylosing spondylitis.
od: Calin, A, et al.
Izdano: (1997)

Susceptibility to ankylosing spondylitis.
od: Carter, N, et al.
Izdano: (2000)

The role of germline polymorphisms in the T-cell receptor in susceptibility to ankylosing spondylitis.
od: Brown, M, et al.
Izdano: (1998)

A genome-wide screen for susceptibility loci in ankylosing spondylitis.
od: Brown, M, et al.
Izdano: (1998)

The X-chromosome and susceptibility to ankylosing spondylitis.
od: Hoyle, E, et al.
Izdano: (2000)

Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis.
od: Brown, M, et al.
Izdano: (1998)

Ankylosing spondylitis: evidence for a non-HLA-B*27 protective effect - Reply
od: Brown, M, et al.
Izdano: (1998)

Genetics of ankylosing spondylitis.
od: Brown, M, et al.
Izdano: (2002)

Ankylosing spondylitis in west Africans - evidence for a non-HLA-B*27 protective effect - reply
od: Brown, M, et al.
Izdano: (1997)

Genetic susceptibility to ankylosing spondylitis.
od: Sims, A, et al.
Izdano: (2004)

Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis.
od: Brown, M, et al.
Izdano: (2000)

Secretor status and ankylosing spondylitis.
od: Pal, A, et al.
Izdano: (1998)

MAPPING THE NON-B27 MHC ASSOCIATIONS OF ANKYLOSING SPONDYLITIS (AS)
od: Sims, A, et al.
Izdano: (2004)

Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis.
od: Jaakkola, E, et al.
Izdano: (2006)

THE ROLE OF ANKH IN ANKYLOSING SPONDYLITIS
od: Timms, A, et al.
Izdano: (2003)

Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect.
od: Brown, M, et al.
Izdano: (1997)

ANKYLOSING-SPONDYLITIS AND FUNCTIONAL ABILITY
od: Wordsworth, B, et al.
Izdano: (1984)

Hypophosphataemia masquerading as ankylosing spondylitis
od: Wordsworth, B, et al.
Izdano: (2008)

TNFR1 and ANKYLOSING SPONDYLITIS
od: Karaderi, T, et al.
Izdano: (2010)

Interleukin-1 and susceptibility to ankylosing spondylitis
od: Edwards, S, et al.
Izdano: (2001)

CANDIDATE GENES FOR ANKYLOSING SPONDYLITIS
od: Pointon, J, et al.
Izdano: (2009)

Investigation of the role of ANKH in ankylosing spondylitis.
od: Timms, A, et al.
Izdano: (2003)

Clinical features of ankylosing spondylitis in the UK
od: Farrar, C, et al.
Izdano: (2008)

ERAP1 and ankylosing spondylitis.
od: Keidel, S, et al.
Izdano: (2013)

Towards defining the genetic determinants of disease severity in ankylosing spondylitis
od: Brophy, S, et al.
Izdano: (2001)

ARTS1 and ankylosing spondylitis
od: Harvey, D, et al.
Izdano: (2008)

Association of Protective HLA-A With HLA-B∗27 Positive Ankylosing Spondylitis
od: Jessika Nordin, et al.
Izdano: (2021-07-01)

Identification of major loci controlling clinical manifestations of ankylosing spondylitis.
od: Brown, M, et al.
Izdano: (2003)

Ankylosing spondylitis (AS) in inflammatory bowel disease (IBD) is associated with possession of HLA-B27 and DR1
od: Orchard, T, et al.
Izdano: (1997)

Towards defining the genetic determinants of disease severity in ankylosing spondylitis.
od: Brophy, S, et al.
Izdano: (2001)

COEXISTENT TOPHACEOUS GOUT AND ANKYLOSING-SPONDYLITIS
od: Portek, I, et al.
Izdano: (1983)